Howard Safir Joins Implant Sciences` Board of Directors

Former Police Commissioner and Fire Commissioner of New York City
WILMINGTON, Mass.--(Business Wire)--
Implant Sciences Corporation (OTCBB:IMSC), a supplier of systems and sensors for
the homeland security market and related industries, today announced the
addition of Howard Safir to the Company`s Board of Directors.

Glenn D. Bolduc, Implant Sciences' Chief Executive Officer, commented, "We are
excited to have Howard Safir join our Board. His long experience with security
and law enforcement and his countless domestic and international associations
will be a great advantage to Implant Sciences."

Mr. Safir noted, "After being introduced to Implant Sciences several months ago,
I conducted my own due diligence on the Company`s products. I found them to have
critical technological, operational and cost advantages versus competing
explosive detection products in the marketplace. As such, I`ve decided to join
Implant`s Board of Directors in order to assist the Company in showcasing its
security solutions to business opportunities requiring advanced detection
capabilities."

Mr. Safir, 67, is Chief Executive Officer of the Security Consulting and
Investigations Unit of GlobalOptions Group, Inc., Mr. Safir has served in that
position since the acquisition of Safir Rosetti, LLC, by GlobalOptions Group in
May 2006. Mr. Safir served as Police Commissioner of New York City from 1996 to
2000 and as New York City`s Fire Commissioner from 1994-1996. Mr. Safir began
his law enforcement career in 1965 as a special agent assigned to the New York
office of the Federal Bureau of Narcotics.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and
systems for the Security, Safety and Defense (SS&D) industries. The Company has
developed proprietary technologies used in its commercial explosive trace
detection systems which ship to a growing number of locations domestically and
internationally. For further details on the Company and its products, please
visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that
term is defined in the Private Securities Litigation Reform Act of 1995. Such
statements are based on management's current expectations and are subject to
risks and uncertainties that could cause the Company's actual results to differ
materially from the forward-looking statements. Such risks and uncertainties
include, but are not limited to, the risks that: because the NYSE Amex has
delisted our common stock, it may be extremely difficult to raise capital; if
third party credit is unavailable, our working capital could be restricted and
we may not be able to borrow capital; and other risks and uncertainties
described in the Company's filings with the Securities and Exchange Commission,
including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on
management's current expectations and assumptions which could differ materially
from the forward-looking statements.

Implant Sciences Corporation
Glenn Bolduc, CEO
978-752-1700
gbolduc@implantsciences.com

Copyright Business Wire 2009